Lamy Patrick
SEC insider (Form 3/4/5 filer). CIK 0001961273. Senior VP, Commercial Strategy at Akero Therapeutics, Inc. (AKRO). 26 reported Form 4/5 transactions since Sep 2024; latest on Dec 9, 2025. Located in SOUTH SAN FRANCISCO, CA.
Companies Lamy Patrick has filed insider reports for
- Akero Therapeutics, Inc. (AKRO): Officer, Senior VP, Commercial Strategy
Lamy Patrick
CIK: 0001961273
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Akero Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (26 total)
- Dec 9, 2025AKRO
Akero Therapeutics, Inc.
DispositionDirect26.8K shares- - Dec 9, 2025AKRO
Akero Therapeutics, Inc.
DispositionDirect3.1K shares- - Jul 1, 2025AKRO
Akero Therapeutics, Inc.
SaleDirect2K shares at avg. $52.88$106K - Jun 30, 2025AKRO
Akero Therapeutics, Inc.
AwardDirect193 shares at avg. $23.87$5K - Jun 20, 2025AKRO
Akero Therapeutics, Inc.
SaleDirect875 shares at avg. $54.59$48K - Jun 16, 2025AKRO
Akero Therapeutics, Inc.
ExerciseDirect2K shares at avg. $19.87$40K - Jun 16, 2025AKRO
Akero Therapeutics, Inc.
SaleDirect1.5K shares at avg. $53.82$81K - Jun 16, 2025AKRO
Akero Therapeutics, Inc.
SaleDirect500 shares at avg. $55.09$28K - Jun 10, 2025AKRO
Akero Therapeutics, Inc.
SaleDirect919 shares at avg. $54.00$50K - Jun 2, 2025AKRO
Akero Therapeutics, Inc.
SaleDirect100 shares at avg. $51.04$5K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | Disposition | 26,832 | - | - | Direct |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | Disposition | 3,059 | - | - | Direct |
| Jul 1, 2025 | AKRO Akero Therapeutics, Inc. | Sale | 2,000 | $52.88 | $105,760 | Direct |
| Jun 30, 2025 | AKRO Akero Therapeutics, Inc. | Award | 193 | $23.87 | $4,607 | Direct |
| Jun 20, 2025 | AKRO Akero Therapeutics, Inc. | Sale | 875 | $54.59 | $47,766 | Direct |
| Jun 16, 2025 | AKRO Akero Therapeutics, Inc. | Exercise | 2,000 | $19.87 | $39,740 | Direct |
| Jun 16, 2025 | AKRO Akero Therapeutics, Inc. | Sale | 1,500 | $53.82 | $80,726 | Direct |
| Jun 16, 2025 | AKRO Akero Therapeutics, Inc. | Sale | 500 | $55.09 | $27,546 | Direct |
| Jun 10, 2025 | AKRO Akero Therapeutics, Inc. | Sale | 919 | $54.00 | $49,625 | Direct |
| Jun 2, 2025 | AKRO Akero Therapeutics, Inc. | Sale | 100 | $51.04 | $5,104 | Direct |
1-10 of 26 transactions